Many Americans hope that the advent of a vaccine will mean the beginning of the end of a pandemic that has cost almost 200,000 U.S. lives and trillions of dollars. But that won’t happen unless people have enough confidence in its safety to take it in sufficient numbers to achieve herd immunity. President Trump’s push to have a vaccine by Election Day has raised concerns that one will be released before it’s been proven safe and effective, prompting nine drugmakers to publicly pledge to avoid shortcuts in clinical trials.

Will it help?

Efthimios Parasidis, who has extensively studied vaccine policy, believes promises won’t be enough. The Ohio State University professor suggests two concrete steps lawmakers could take that would do a lot more to build public confidence in a vaccine.

Also today:

Bryan Keogh

Senior Editor, Economy + Business

A patient receives a shot in a clinical trial for a COVID-19 vaccine. AP Photo/Ted S. Warren

Big pharma’s safety pledge isn’t enough to build public confidence in COVID-19 vaccine – here’s what will

Efthimios Parasidis, The Ohio State University

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Arts + Culture

Science + Technology

Politics/Election '20

Ethics + Religion


Trending on Site